The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
Official Title: Phase I/II Study of Proton Beam Therapy for Hepatocellular Carcinoma
Study ID: NCT00614913
Brief Summary: This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.
Detailed Description: Hepatocellular carcinoma (HCC) is a type of primary cancer of the liver that is being diagnosed in the U.S. population with increasing frequency. While surgery is the first line of treatment, many patients are not eligible for surgical removal. Current non-surgical treatments for HCC are not fully effective and can have substantial side-effects. This study utilizes a type of radiation treatment called proton beam that can deliver high doses of radiotherapy to tumors within the liver while minimizing damage to surrounding healthy tissues. The treatment is non-invasive and is given on an out-patient basis over a three week coarse. The study will evaluate the effectiveness and side-effects of this therapy by tracking patient's outcomes following treatment.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Loma Linda University Medical Center / James M. Slater Proton Treatment Center, Loma Linda, California, United States
Name: David A Bush, MD
Affiliation: Loma Linda University Dept. of Radiation Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Jerry D Slater, MD
Affiliation: Loma Linda University Department of Radiation Medicine
Role: STUDY_CHAIR